{"organizations": [], "uuid": "8bcf9b7c9a22595c5896f778617aa95078803d2c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180214.html", "section_title": "Archive News &amp; Video for Wednesday, 14 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-pacira-pharmaceuticals-says-fda-ad/brief-pacira-pharmaceuticals-says-fda-advisory-committee-to-review-snda-for-exparel-idUSFWN1Q41DW", "country": "US", "domain_rank": 408, "title": "BRIEF-Pacira Pharmaceuticals Says FDA Advisory Committee To Review SNDA For Exparel", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.516, "site_type": "news", "published": "2018-02-15T03:52:00.000+02:00", "replies_count": 0, "uuid": "8bcf9b7c9a22595c5896f778617aa95078803d2c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-pacira-pharmaceuticals-says-fda-ad/brief-pacira-pharmaceuticals-says-fda-advisory-committee-to-review-snda-for-exparel-idUSFWN1Q41DW", "ord_in_thread": 0, "title": "BRIEF-Pacira Pharmaceuticals Says FDA Advisory Committee To Review SNDA For Exparel", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "pacira pharmaceuticals inc", "sentiment": "negative"}, {"name": "brief-pacira pharmaceuticals says fda advisory committee to review snda", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 14 (Reuters) - Pacira Pharmaceuticals Inc:\n* PACIRA PHARMACEUTICALS STOCK TRADING HALTED; FDA ADVISORY COMMITTEE TO REVIEW SNDA FOR EXPARELÂ® AS A NERVE BLOCK FOR REGIONAL ANALGESIA Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-15T03:52:00.000+02:00", "crawled": "2018-02-15T20:48:10.023+02:00", "highlightTitle": ""}